AACR And Pancreatic Cancer Action Network Provide Over $1.2 Million In Funds For Pancreatic Cancer Research

Main Category: Pancreatic Cancer
Article Date: 16 Oct 2008 - 5:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

The American Association for Cancer Research is accepting applications for grants supporting pancreatic cancer research. The deadline for applications is November 10, 2008. The grant terms will begin on July 1, 2009.

Pancreatic cancer is the fourth leading cause of cancer death in the United States. In a mission to accelerate pancreatic cancer research, the Pancreatic Cancer Action Network has partnered with the AACR on three initiatives to promote and support outstanding research focused on conquering this deadly disease.

Pancreatic Cancer Action Network-AACR Pilot Grants, ranging from $100,000 to $200,000 over the two-year grant term, are open to independent investigators and support new ideas and innovative models that have direct application and demonstrate direct relevance to pancreatic cancer. In addition to pancreatic cancer researchers, investigators with experience in other areas of cancer research who have promising and realistic ideas or research approaches that can be applied to pancreatic cancer are also invited to apply. Special emphasis will be placed on research that is not duplicative of other efforts. Up to six grants will be awarded.

Pancreatic Cancer Action Network- AACR Career Development Awards provide $100,000 over the two-year grant term to junior faculty who are in their first full-time appointment and have completed postdoctoral studies or clinical fellowships no more than three years prior to the start of the grant term. Five grants will be awarded.

Pancreatic Cancer Action Network- AACR Research Fellowship provides a one-year grant of $45,000 to Postdoctoral Fellows or Clinical Research Fellows who will be in the 1st, 2nd, or 3rd year of their postdoctoral training at the start of the fellowship term. One grant will be awarded.

The AACR is honored to partner with the Pancreatic Cancer Action Network, an organization which has shown tremendous dedication to pancreatic cancer research. Since establishing this partnership to award research grants in 2003, the Pancreatic Cancer Action Network and the AACR have provided over $2.8 million to support 27 pancreatic cancer research grants. With the commitment of funds for 2009, total support for pancreatic cancer research will total over $4.06 million. Funding decisions are based on a rigorous peer review system to ensure that the highest quality science is supported. Past recipients have cited these grants as a strong positive factor in their career development and in generating preliminary data that qualified the recipients for larger federal and private grants.

For more information on eligibility criteria, the application process, and other details about the Pancreatic Cancer Action Network-AACR funding opportunities, please visit: www.aacr.org/page 14765.aspx Inquiries from investigators should be directed to Hanna Hopfinger at hanna.hopfinger(at)aacr.org.

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 28,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and 80 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment, and patient care. AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. Its most recent publication and its sixth major journal, Cancer Prevention Research, is dedicated exclusively to cancer prevention, from preclinical research to clinical trials. The AACR also publishes CR, a magazine for cancer survivors, patient advocates, their families, physicians, and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship, and advocacy.

www.aacr.org